lit-0057
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis
Krause PJ, Auwaerter PG, Bannuru RR, Branda JA, Falck-Ytter YT, Lantos PM, et al. (2021). Clinical Infectious Diseases.
Study design and applicability are separate. A rigorous design in an unmatched population is not “strong evidence” for this record.
Status: Bibliographic identity verified (identifier match only). Identifier resolution proves bibliographic identity only; it does not prove that the card summary supports any medical claim, and it is not clinician review. Semantic verification count remains 0 for the catalog.
Primary IDSA evidence-based guideline. Prefers smear/PCR over antibody for acute confirmation. Frames prolonged/relapsing disease mainly in immunocompromised hosts. Guideline is silent on FISH LDTs; smear/PCR standard is the published position — not treating FISH as endorsed. Published corrigendum (Clin Infect Dis 2021 doi 10.1093/cid/ciab275, PMID 33960362) — check publisher record.
Record overlap notes (research). commercial PCR preferred for confirmation; atovaquone-based regimens standard; serology not for acute confirmation
DOI: 10.1093/cid/ciaa1216 · PMID: 33252652 · PMCID: —
Open external bibliographic record
Full text is not hosted here. Local PDFs are not published. Paywalled PDFs are never offered.
What cites this on the site
- Question CQ-009